Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A van Os

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Community Genetics|June 5, 2004
Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general populationM F Wildhagen, T A van Os, J J Polder, et al.
Journal of Medical Screening|August 13, 1999
Efficacy of cascade testing for fragile X syndromeM F Wildhagen, T A van Os, J J Polder, et al.
Prenatal Diagnosis|February 17, 2001
Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF)L Henneman, I Bramsen, T A Van Os, et al.
Familial Cancer|January 5, 2019
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortJ J Bakhuizen, F B Hogervorst, M E Velthuizen, et al.
British Journal of Cancer|December 8, 2011
Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD familiesA C Houweling, L M Gijezen, M A Jonker, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Community Genetics|June 5, 2004
Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general populationM F Wildhagen, T A van Os, J J Polder, et al.
Journal of Medical Screening|August 13, 1999
Efficacy of cascade testing for fragile X syndromeM F Wildhagen, T A van Os, J J Polder, et al.
Prenatal Diagnosis|February 17, 2001
Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF)L Henneman, I Bramsen, T A Van Os, et al.
Familial Cancer|January 5, 2019
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortJ J Bakhuizen, F B Hogervorst, M E Velthuizen, et al.
British Journal of Cancer|December 8, 2011
Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD familiesA C Houweling, L M Gijezen, M A Jonker, et al.
Pageof 1